Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
5.90
+0.02 (0.34%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Puma Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
29.6469.2284.5976.263.13
Short-Term Investments
67.8931.7511.354.8718.98
Cash & Short-Term Investments
97.53100.9795.9481.0782.11
Cash Growth
-3.40%5.24%18.34%-1.26%-12.08%
Accounts Receivable
53.6532.0147.8440.3532.53
Inventory
5.528.727.084.537.11
Other Current Assets
5.995.965.338.3318.28
Total Current Assets
162.69147.66156.19134.28140.02
Net Property, Plant & Equipment
5.565.098.6512.5115.77
Other Intangible Assets
41.3951.1360.8770.6166.13
Other Long-Term Assets
6.669.454.834.664.67
Total Assets
216.3213.33230.53222.06226.59
Accounts Payable
5.065.516.896.4411.17
Accrued Expenses
50.0336.952.7265.5392.58
Current Portion of Long-Term Debt
22.5245.3334--
Current Portion of Leases
1.315.544.84.143.57
Other Current Liabilities
2.332.840.981.372.26
Total Current Liabilities
81.2596.1199.3877.48109.59
Long-Term Debt
-21.7265.6698.3197.09
Long-Term Leases
4.711.497.0311.8315.98
Other Long-Term Liabilities
-1.885.0112.836.38
Total Long-Term Liabilities
4.7125.177.7122.97119.45
Total Liabilities
85.96121.21177.09200.45229.03
Common Stock
0.010.010.010.010
Additional Paid-in Capital
1,4141,4071,3991,3881,364
Accumulated Other Comprehensive Income
0.040.01-0--0
Retained Earnings
-1,284-1,315-1,345-1,367-1,367
Shareholders' Equity
130.3492.1353.4421.61-2.45
Total Liabilities & Equity
216.3213.33230.53222.06226.59
Total Debt
28.5574.08111.49114.28116.64
Net Cash (Debt)
68.9826.88-15.55-33.21-34.54
Net Cash Growth
156.60%----
Net Cash Per Share
1.360.55-0.33-0.74-0.85
Book Value
130.3492.1353.4421.61-2.45
Book Value Per Share
2.571.881.120.48-0.06
Tangible Book Value
88.9540.99-7.43-49-68.57
Tangible Book Value Per Share
1.760.83-0.16-1.09-1.69
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q